Teligent Basic EPS 2010-2021 | TLGT
Teligent basic eps from 2010 to 2021. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| Teligent Annual Basic EPS |
| 2020 |
$-14.67 |
| 2019 |
$-4.67 |
| 2018 |
$-6.80 |
| 2017 |
$-2.80 |
| 2016 |
$-2.30 |
| 2015 |
$1.30 |
| 2014 |
$1.10 |
| 2013 |
$-0.30 |
| 2012 |
$-1.00 |
| 2011 |
$-0.80 |
| 2010 |
$-2.00 |
| 2009 |
$-4.60 |
| Teligent Quarterly Basic EPS |
| 2021-06-30 |
$-0.14 |
| 2021-03-31 |
$0.04 |
| 2020-12-31 |
$-7.05 |
| 2020-09-30 |
$-0.08 |
| 2020-06-30 |
$-2.56 |
| 2020-03-31 |
$-4.98 |
| 2019-12-31 |
$-1.01 |
| 2019-09-30 |
$-1.32 |
| 2019-06-30 |
$-0.74 |
| 2019-03-31 |
$-1.60 |
| 2018-12-31 |
$-2.70 |
| 2018-09-30 |
$-0.70 |
| 2018-06-30 |
$-2.50 |
| 2018-03-31 |
$-0.90 |
| 2017-12-31 |
$-1.10 |
| 2017-09-30 |
$-1.70 |
| 2017-06-30 |
$-0.20 |
| 2017-03-31 |
$0.20 |
| 2016-12-31 |
$-1.10 |
| 2016-09-30 |
$-0.50 |
| 2016-06-30 |
$-0.50 |
| 2016-03-31 |
$-0.20 |
| 2015-12-31 |
$-1.20 |
| 2015-09-30 |
$-0.50 |
| 2015-06-30 |
$1.80 |
| 2015-03-31 |
$1.20 |
| 2014-12-31 |
$1.20 |
| 2014-09-30 |
$0.00 |
| 2014-06-30 |
$-0.10 |
| 2014-03-31 |
$0.00 |
| 2013-12-31 |
$-0.08 |
| 2013-09-30 |
$-0.02 |
| 2013-06-30 |
$-0.10 |
| 2013-03-31 |
$-0.10 |
| 2012-12-31 |
$-0.30 |
| 2012-09-30 |
$-0.40 |
| 2012-06-30 |
$-0.10 |
| 2012-03-31 |
$-0.20 |
| 2011-12-31 |
$-0.20 |
| 2011-09-30 |
$-0.10 |
| 2011-06-30 |
$-0.20 |
| 2011-03-31 |
$-0.30 |
| 2010-12-31 |
$0.10 |
| 2010-09-30 |
$-0.80 |
| 2010-06-30 |
$-0.60 |
| 2010-03-31 |
$-0.70 |
| 2009-12-31 |
$-0.50 |
| 2009-09-30 |
$-0.50 |
| 2009-06-30 |
$-2.30 |
| 2009-03-31 |
$-1.30 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
